Page 20 - Functional Genomics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Author of the article: Nugget Staff Publishing date: Mar 16, 2021  •  March 16, 2021  •  2 minute read  •  Tara McGoey, left, outlines some of the results of a DNA sequencing operation to Kashif Khan, CEO of The DNA Company, Nipissing-Timiskaming MP Anthony Rota and Canadore College president George Burton, in September, 2019, at the official opening of the Functional Genomics Lab at Canadore. The lab will be part of a provincewide effort to sequence and characterize coronavirus strains. Nugget File Photo Article content Canadore College is joining the effort to sequence and ...

Scientists to extract ancient bacteria from Batagai depression in bid to create new antibiotic range 04 March 2021 Expedition to the world’s biggest permafrost ‘crater’ in Yakutia seeks secret of taming antimicrobial resistance. 'We see that the situation with antibiotic resistance is very difficult indeed, and it is in the interests of both us (as scientists) and society to obtain prototypes of drugs for the treatment of hospital-obtained infections, and then bring them to production’, said Dr Artemy Goncharov, head of the Laboratory of Functional Genomics and Proteomics of...

A little more than two centuries ago, an English novelist named Frances Burney endured a “terrible operation” to remove a tumour after having breast cancer diagnosed. Burney spent more than 17 agonising minutes under the scalpel as her surgeon in Paris cut away at her breast – all without anaesthetic. She was 58 when the mastectomy was performed and lived another three decades, a happy outcome that went against the terrible odds faced by cancer patients at the time. Fast forward to today and the cancer treatments being contemplated by Prof Dan Peer at Tel Aviv University in Israel a...

Press release content from Business Wire. The AP news staff was not involved in its creation. Athersys Announces CEO Transition CLEVELAND, Ohio--(BUSINESS WIRE)--Feb 16, 2021-- Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem ® cell therapy, today announced that Dr. Gil Van Bokkelen has stepped down as Chairman and Chief Executive Officer, effective immediately. The Athersys Board has appointed William (B.J.) Lehmann, the Company’s President and Chief Operating Officer, as Interim Chief Executive Officer. Dr. Ismail Kola, Lead Director of the Athersys Boa...

Homegrown coronavirus variants are on the rise in the U.S. How worried should Americans be? Andrew Romano © Provided by Yahoo! Lifestyle In recent weeks, Americans have been waiting with bated breath for the arrival of worrisome overseas variants of SARS-CoV-2 — the coronavirus that causes COVID-19. We’ve all heard of B.1.1.7 (the so-called U.K. variant), B.1.351 (the so-called South Africa variant) and P.1 (the so-called Brazil variant). We’re dimly aware of how they work, with various spike-protein mutations that confer certain advantages, making them more transmissi...